Description

n-(2-(1H-Indol-3-Yl)Ethyl)-4-(2,4-Dioxo-1,4-Dihydroquinazolin-3(2H)-Yl)Butanamide is a high-purity, synthetic organic compound featuring a unique molecular architecture combining indole and quinazoline moieties. This structure makes it a valuable advanced pharmaceutical intermediate and a key building block for medicinal chemistry research. It is primarily utilized by R&D organizations and manufacturers in the pharmaceutical and biotechnology sectors. The compound is supplied to meet the stringent quality requirements necessary for drug discovery and development processes.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis of novel active pharmaceutical ingredients (APIs) targeting central nervous system (CNS) disorders, oncology, and other therapeutic areas.
• Medicinal Chemistry Research: Used as a scaffold or building block for structure-activity relationship (SAR) studies and the development of new chemical entities in drug discovery programs.
• Biochemical Research: Employed in biochemical assays and as a tool compound to study enzyme inhibition or receptor binding activities related to its structural features.
• Reference Standard: Supplied as a high-purity analytical standard for quality control and method development in analytical laboratories.
• Custom Synthesis: Acts as a starting material for the custom synthesis of more complex, target-specific molecules for preclinical and clinical research.

Basic Information

Product Name	n-(2-(1H-Indol-3-Yl)Ethyl)-4-(2,4-Dioxo-1,4-Dihydroquinazolin-3(2H)-Yl)Butanamide
CAS No.	919730-74-8
Molecular Formula	C22H20N4O3
Molecular Weight	388.42 g/mol
Synonyms	3-[2-[2-(1H-Indol-3-yl)ethylamino]-2-oxoethyl]-2,4(1H,3H)-quinazolinedione; 4-(2,4-Dioxo-1,4-dihydro-3(2H)-quinazolinyl)-N-[2-(1H-indol-3-yl)ethyl]butanamide; N-[2-(1H-Indol-3-yl)ethyl]-4-(2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)butanamide; Butanamide, N-[2-(1H-indol-3-yl)ethyl]-4-(2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)-; 919730-74-8; Quinazoline-indole derivative; Indole-quinazoline conjugate
EINECS	Contact for details

Quality Control

Our n-(2-(1H-Indol-3-Yl)Ethyl)-4-(2,4-Dioxo-1,4-Dihydroquinazolin-3(2H)-Yl)Butanamide is manufactured under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation (IR, NMR), to ensure it meets exacting specifications for research and development use. Certificates of Analysis (COA) with detailed chromatographic data are provided and available upon request to support your regulatory and quality documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The product is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.